Despite the availability of vaccines, human papillomavirus (HPV) infections remain a cause of significant cancer morbidity and mortality. We have previously shown that HPV16 E7 associates with and diminishes E2F6-containing polycomb repressive complexes. Here, we show that repressive trimethyl marks on lysine 27 of histone 3, which are necessary for binding of polycomb repressive complexes, are decreased in HPV16 E7-expressing cells and HPV16-positive cervical lesions. This is caused by transcriptional induction of the KDM6A and KDM6B histone 3 lysine 27-specific demethylases. HPV16 E7-mediated KDM6B induction accounts for expression of the cervical cancer biomarker, p16
H uman papillomaviruses (HPVs) are small double-stranded DNA viruses that are associated with epithelial hyperplasias. A subgroup of high-risk HPVs is etiologic agents of cervical carcinomas as well as other anogenital cancers and oropharyngeal tumors (reviewed in ref. 1) . Because of frequent integration of the viral genome into a host cell chromosome, E6 and E7 are the only viral proteins that are consistently expressed in HPVassociated cancers. E6 and E7 have oncogenic activities, and their expression is necessary for the induction and maintenance of the transformed phenotype (reviewed in ref. 2) .
The HPV E6 and E7 proteins lack intrinsic enzymatic activities and do not act as DNA binding transcription factors; rather, they reprogram their host cells by associating with cellular signaling molecules. High-risk HPV E6 proteins target the p53 tumor suppressor for degradation, thereby thwarting p53-mediated transcriptional cytostatic and cytotoxic responses to cellular stress signals. High-risk HPV E7 oncoproteins associate with and degrade the retinoblastoma tumor suppressor (pRB), which acts as a cell cycle-specific repressive subunit of several E2F transcriptional complexes, and thereby, subvert cell cycle-dependent E2F transcriptional activities (reviewed in ref. 2) . The HPV E6 and E7 oncoproteins also associate with enzymes that modulate histone acetylation and thus, broadly regulate the transcriptional competence of host cell chromatin (3) (4) (5) (6) (7) (8) .
We have previously reported that the HPV16 E7 oncoprotein associates with E2F6-containing polycomb transcriptional repressor complexes (PRCs) and that the detection of these complexes is reduced in HPV16 E7-expressing cells (9) . PRCs require the histone H3 lysine 27 trimethyl (H3K27me3) mark to associate with and transcriptionally silence chromatin (reviewed in ref. 10) . PRCs have been most extensively studied in Drosophila melanogaster (reviewed in ref. 11 ), where they establish and sustain lineage-specific epigenetic silencing of Homeobox (HOX) genes during development (12, 13) . HOX proteins are master regulators of transcriptional programs that create and maintain cellular identities. Other PRC-regulated genes include the INK4A-ARF tumor suppressor locus, which encodes p16 INK4A , an inhibitor of cyclin-dependent kinases (CDK) 4 and 6, and p14
ARF , an inhibitor of mdm2-mediated p53 degradation (14) . Silencing through H3K27me3 involves PRC2 and PRC1. The catalytic subunit of PRC2, EZH2, is a methyl transferase that catalyzes di-and trimethylation of H3K27, which is then recognized by PRC1 (reviewed in ref. 15 ). The repressive H3K27me3 mark can be removed by one of two known histone demethylases, KDM6A (UTX) and KDM6B (JMJD3). KDM6B has been shown to remove H3K27me3 marks from the p16 INK4A promoter during ras/raf oncogene-induced cellular senescence (16, 17) , whereas KDM6A has been implicated in the removal of H3K27me3 marks from the promoters of several genes encoding RB-binding proteins (18) .
Here, we report that HPV16 E7 expression results in a dramatic reduction of the H3K27me3 mark necessary for the binding of PRC1 through transcriptional induction of the histone demethylases KDM6A and KDM6B. We discovered that increased expression of the cervical carcinoma biomarker p16
INK4A is specifically linked to KDM6B induction. Induction of KDM6B and its transcriptional target p16
INK4A by HPV16 E7 is not dependent on pRB inactivation and hence, is not linked to E2F activation. Because HPV16 E7 simultaneously inactivates the critical mediator of p16
INK4A
-induced senescence, pRB, HPV16 E7-expressing cells escape senescence and continue to proliferate, and several known KDM6A-or KDM6B-regulated HOX genes are expressed at higher levels in such cells. Hence, HPV16 E7 expression causes epigenetic reprogramming of host cells at the level of histone methylation. Because these HPV16 E7-induced alterations in H3K27me3 levels and associated transcriptional changes are rapidly reversible on silencing of E7 expression and because depletion of KDM6A and KDM6B inhibit proliferation of CaSki cervical cancer cells, our results suggest that KDM6A and KDM6B may be targets for therapy of HPV-associated lesions and cancers.
Results
H3K27me3 Levels Are Reduced in HPV16 E7-Expressing Primary Human Epithelial Cells. We have previously shown that HPV16 E7 binds to E2F6-containing PRCs and that detection of these complexes is reduced in HPV16 E7-expressing cells (9) . E2F6-containing PRCs bind to H3K27me3 transcriptional repressive marks. To determine if the reduced detection of E2F6-containing PRCs in HPV16 E7-expressing cells was accompanied by alterations in the H3K27me3 transcriptional repressive mark, we compared the levels of mono-, di-, and trimethylated H3K27 by immunofluorescence in donor and passage-matched primary human foreskin keratinocyte (HFK) populations that were engineered to express HPV16 E7 (HFK/E7) or were infected with an empty retroviral control vector. These experiments revealed a striking reduction in the intensity of H3K27me3 staining in HFK/E7 cells. In contrast, there was no detectable reduction of H3K27me1 and H3K27me2 or total H3 staining in HFK/E7 compared with control HFKs (Fig. 1A) . A reduction of H3K27me3 levels in HFK/E7 was also detected by Western blotting (Fig. 1B) .
Expression of the H3K27-Specific Demethylases KDM6A and KDM6B Is Increased in HPV16 E7-Expressing Primary Human Epithelial Cells.
H3K27me3 repressive marks are placed by the histone methyltransferase containing PRC2 (19) (20) (21) (22) and are removed by the histone demethylases KDM6A and KDM6B (23) (24) (25) (26) . To determine if levels of the histone demethylases KDM6A and KDM6B were increased in HPV16 E7-expressing cells, we performed immunofluorescence analyses in HFK/E7 cells and donorand passage-matched control HFKs. These experiments revealed a striking increase of KDM6A and KDM6B levels in HFK/E7s compared with control HFKs (Fig. 2A) . Increased expression of KDM6A and KDM6B in HFK/E7 cells was also detected by Western blot analysis (Fig. 2B) . Quantitative real-time RT-PCR (qRT-PCR) experiments revealed that KDM6A and KDM6B mRNA levels are increased in HFK/E7 cells (Fig. 2C) , and thus, the mechanism of induction is at least in part transcriptional. Consistent with a previous report (27) , EZH2 mRNA expression was also increased in HFK/E7 cells (Fig. S1 ).
HPV16 E7-Mediated Induction of the Cervical Cancer Biomarker p16
INK4A Is Mediated by KDM6B. The CDK4/6 inhibitor and tumor suppressor p16
INK4A is highly expressed in high-risk HPV-associated lesions and cancers and is an excellent biomarker for such malignancies (28, 29) . KDM6B controls induction of p16 INK4A in response to oncogenic stress by ras/raf (16, 17) . Given that HPV16 E7 induces expression of both p16
INK4A (30) and KDM6B ( Fig. 2 INK4A levels compared with control siRNA transfected cells, whereas p14 ARF levels were unchanged (Fig. 3B ).
HPV16 E7-Mediated Induction of KDM6B and Its Target p16
INK4A Is Not Dependent on pRB Inactivation. To determine whether HPV16 E7-mediated pRB inactivation provides a necessary oncogenic stress signal that causes induction of KDM6B expression, we compared expression of KDM6B and its target p16 INK4A by Western blotting in donor-and passage-matched primary human fibroblasts with expression of WT HPV16 E7 or the pRB-binding/degradationdeficient HPV16 E7 delD21-C24 mutant as well as control vectortransduced cells. Expression of the HPV16 E7 delD21-C24 mutant robustly increased KDM6B and p16
INK4A levels (Fig. 4) . Hence, up-regulation of KDM6B and its transcriptional target p16
INK4A by HPV16 E7 is not dependent on pRB inactivation. 6A) , with concomitant decreases in the H3K27me3 mark (Fig.  6B ). These changes were abolished when HPV16 E7 expression was reduced by removal of doxycycline (Fig. 6) . Hence, the observed induction of KDM6B expression, associated decreases in H3K27me3 levels, and induction of p16
INK4A expression are a direct consequence of HPV16 E7 expression, and these alterations are reversible on silencing of HPV16 E7 expression.
To compare the ratio of H3K27me3 to total H3 throughout the INK4A-ARF locus before and after induction of HPV16 E7, we performed ChIP experiments. Consistent with our previous results (Fig. 1) , the H3K27me mark was virtually absent from the INK4A-ARF locus when HPV16 E7 was expressed (Fig. 6C) . There was an increase in the H3K27me3 mark around the transcriptional start site of INK4A on depletion of KDM6B but not when KDM6B was depleted (Fig. 6C) . Consistent with this result, we observed increased KDM6B binding around the INK4A transcriptional start site on HPV16 E7 expression (Fig. 6D) . Because of the lack of appropriate antibodies, KDM6A binding at the INK4A-ARF locus could not be evaluated by ChIP. Consistent with the observed increase in EZH2 expression, we observed increased EZH2 binding along the INK4A-ARF locus (Fig. S3 ).
KDM6A and KDM6B Depletion Causes Growth Suppression in a Cervical Carcinoma Line. To investigate whether high-level expression of KDM6A and KDM6B cells may modulate the transformed phenotype of HPV16-transformed cells, we depleted KDM6A or KDM6B in the HPV16-positive CaSki cervical carcinoma cells followed by colony formation assays. The number of colonies was reduced by ∼50% when either KDM6A or KMD6B was depleted (Fig. 7) .
Discussion
We discovered that HPV16 E7 expression causes a marked reduction in the H3K27me3 repressive epigenetic mark (Fig. 1) , and a similar decrease was also evident in HPV16-positive cervical lesions (Fig. 3A) . A previous report showed that HPV16 E7 induces expression of the histone methyl transferase component of PRC2, EZH2 (27) , and we confirmed this result in our studies (Fig. S1 ). EZH2 overexpression and increased binding to the p16 INK4A promoter (Fig. S3 ) may seem at odds with our finding that the H3K27me3 mark is decreased in HPV16 E7-expressing cells (Fig. 1) . It has been shown, however, that EZH2 overexpression does not result in increased PRC2 activity but instead, enhances PRC4 formation (32) . PRC4 causes histone H1K26 deacetylation and methylation (32) , which then serves as a binding site for the lethal(3)malignant brain tumor-like 1 (L3MBTL1) polycomb group protein. Hence, increased EZH2 expression in E7-expressing cells may be predicted to cause enhanced H1K26 methylation. Intriguingly, HPV16 E7 is associated with the L3MBTL2 protein (9), which is closely related to L3MBTL1 (33) , and it will be interesting to determine whether the predicted increase in EZH2-containing PRC4 complexes and association with L3MBTL2 may alter H1K26 methylation (Fig. 7) .
The observed decrease in the repressive H3K27me3 mark is mediated by transcriptional induction of the two H3K27-specific histone demethylases, KDM6A and KDM6B (Fig. 2) . The concept that a viral oncoprotein affects expression of histone demethylases to alter the epigenetic memory of host cells has not been previously appreciated. KDM6A and KDM6B have each been implicated in tumor development. KDM6A is a bona fide tumor suppressor, and somatic mutations have been detected in multiple human tumor types. KDM6B is also a potential tumor suppressor, because the KDM6B gene is located at 5q31, an area that is frequently lost in multiple cancer types (reviewed in ref. 34 ). Conversely, KDM6B overexpression may also have oncogenic activities, because its expression is increased in prostate cancer, most dramatically in metastatic tumors (35) . Our results that KDM6A or KDM6B depletion inhibits proliferation of CaSki cervical cancer cells (Fig. 7) are consistent with this model.
The experiments presented here also establish the elusive mechanism for induction of the CDK4/6 inhibitor and cervical cancer biomarker p16
INK4A by HPV16 E7. A previous study suggested that HPV16 E7 may induce p16 INK4A expression INK4A , and p14 ARF levels from three independent experiments are shown on the bar graph in Right. Statistically significant decreases (P < 0.05) are indicated by an asterisk.
Fig. 4. HPV16 E7-mediated induction of KDM6B and its transcriptional target p16
INK4A are not dependent on the ability of HPV16 E7 to degrade pRB. Western blot analysis of KDM6B and p16
INK4A expression in donor-and passage-matched populations of primary human fibroblasts (HFFs) expressing WT HPV16 E7, the pRB binding/degradation-deficient HPV16 delD21-24 mutant, and control vector-infected HFFs. An E7 blot shows similar expression of WT and mutant E7, and an actin blot is show as a loading control.
through an E2F-dependent pathway and that increased p16 INK4A induction is independent of pRB inactivation (Fig. 4 ) and is mediated by KDM6B. Hence, it is tempting to speculate that increased p16
INK4A expression in high-risk HPV-associated lesions and tumors may represent a cellular response to HPV16 E7-induced oncogenic stress similar to what has been reported for ras/raf (16, 17) . Induction of p16
INK4A as a consequence of ras/rafmediated oncogenic stress has been recently documented in vivo by an analysis of mice expressing K-ras G12D in enterocytes (36) . Interestingly, p16
INK4A expression was no longer observed in malignant tumors, supporting the notion that p16 INK4A induction in response to an oncogenic stimulus may represent a critical cell intrinsic tumor suppressive mechanism that needs to be overcome during malignant progression, presumably by an additional cellular mutation (36) . Although HPV16 E7 triggers increased p16
INK4A expression, it simultaneously neutralizes the key mediator of p16
INK4A -induced senescence, pRB, and HPV16 E7-expressing cells continue to proliferate, despite high levels of p16 INK4A expression. Based on these findings, one might suggest the somewhat heretical hypothesis that mutations that target the pRB pathway, which occur in the majority of human solid tumors, are not to induce uncontrolled proliferation, as is commonly assumed, but are to abrogate the p16 INK4A -mediated senescence response induced by oncogenic stress (Fig. 8) .
Unlike ras/raf, which only causes increased expression of KDM6B (16, 17) , HPV16 E7 expression also triggers increased expression of the related KDM6A (Fig. 2) . It is possible that KDM6A induction by HPV16 E7 expression also represents ChIP assays using lysates from U2OS-tet on cells with or without doxycycline-inducible expression of HPV16 E7. In C, an antibody specific for H3K27me3 was used, and in D, an antibody specific to KDM6B was used. qPCR was used to measure the degree of enrichment. The H3K27me3 signal was normalized to histone H3 bound, and the KDM6B results are presented as a percentage of bound/input. Statistically significant changes (P < 0.05) are indicated by an asterisk. a cellular defense response, perhaps mediated by different molecular triggers than KDM6B. A systematic investigation into the molecular triggers and mechanisms that drive KDM6A and KDM6B induction by HPV16 E7 is currently in progress.
It is clear, however, that HPV16 E7 induces expression of these histone demethylases through pathways that are distinct from the normal mechanism of KDM6B induction during epithelial differentiation, where recruitment to promoters is enhanced, whereas overall KDM6B levels are not altered (37) . The transcriptional induction of KDM6A and KDM6B by HPV16 E7, however, is reminiscent of the induction of these enzymes during wound healing (38) . Because HPV infects the proliferating basal layer of the epithelium through microabrasions, the initial stages of the HPV life cycle likely occur in a wound-healing environment. Moreover, cellular activities related to wound healing may increase the efficiency with which HPV genomes become established in basal cells (39) , and HPV infection has been reported to maintain cells in a wound healing-like state (40) . HPV16 E7-mediated transcriptional induction of KDM6A and KDM6B may, therefore, contribute to maintaining a wound-healing state that may be beneficial for the viral life cycle.
Because HPV16 E7-expressing cells continue to proliferate in the presence of high-level KDM6A and KDM6B expression, one predicts that such cells are epigenetically reprogrammed. Consistent with this model, our studies document dysregulated HOX gene expression in HPV16 E7-expressing cells (Fig. 5) . Of particular interest are HOXC5 and HOXC8, which have previously been reported to be up-regulated in cervical carcinomas (41) . HOX genes have been implicated in the regulation of adult skin (42) (43) (44) . Thus, one possible consequence of abnormal HOX gene expression in HPV-infected cells may be an altered differentiation state of the epithelium that may be conducive to the viral life cycle.
In addition, alterations in HOX gene expression patterns may modify the stemness of the infected host cell. One might, therefore, speculate that HPV16-infected basal epithelial cells may be reprogrammed to a more stem-like state. This would represent an attractive mechanism to guarantee long-term maintenance of HPV genomes in infected epithelial cells. Such a mechanism may also have important implications with respect to the oncogenic activities of high-risk HPVs. One possibility is that HPV16 E7-induced epigenetic alterations, potentially in concert with other activities of the HPV16 E7 and/or HPV16 E6 oncoproteins, may contribute to the development of a cancer stem cell (reviewed in ref. 45) .
Dysregulation of HOX gene expression is frequently observed in human tumors, and some HOX genes are bona fide oncogenes or tumor suppressors (reviewed in ref. 11). In addition to altering the stemness of the cell, dysregulated HOX gene expression has also been linked to other pathways that promote tumorigenesis, including differentiation, invasion and epithelial-to-mesenchymal transition (EMT), apoptosis, proliferation, and receptor signaling (reviewed in ref. 11).
Alterations of patterns of DNA methylation and histone modifications are often found early in tumorigenesis and may be key initiating events in certain cancers (reviewed in ref. 46 ). Because, unlike genetic mutations, epigenetic aberrations are potentially reversible, they constitute a ripe target for therapeutic intervention. Our findings that HPV16 E7-induced epigenetic and related transcriptional alterations are reversible on silencing of E7 expression (Fig. 6) and that KDM6A or KDM6B depletion inhibits proliferation of CaSki cervical cancer cells suggest that inhibition of KDM6A and/or KDM6B may be therapeutic modalities for HPV-associated lesions and cancers.
Materials and Methods
Cells. Primary HFKs and fibroblasts (HFFs) were isolated and cultured as described (9) . Cells with stable expression of WT or mutant HPV16 E7 were generated by infecting with pBABE, pBABE-16E7 (47), and pBABE-E7 delD21-C24 (9) that were produced as described (47) . Early passage HKFs immortalized by an integrated head to tail dimer of the HPV16 genome, Hkc/HPV16 (48), were kindly provided by Kim Creek and Lucia Pirisi (University of South Carolina School of Medicine, Columbia, SC) and were maintained in keratinocyte serum free media (KSFM) (Gibco/Invitrogen). Organotypic (raft) cultures were grown as described (49) and were allowed to stratify for 10 d. U2OS-tet on cells was maintained in DMEM supplemented with 10% tet system-approved FBS, 50 U/mL penicillin, 50 μg/mL streptomycin, and 250 μg/mL G418. CaSki cells (ATCC) were maintained in DMEM with 10% newborn calf serum (NCS), 50 U/mL penicillin, and 50 μg/mL streptomycin.
Western Blotting. Cell lysates were prepared and processed as described (9) . Antibodies used are described in SI Materials and Methods. Antigen/antibody complexes were visualized by enhanced chemiluminescence (PerkinElmer Life Sciences) and exposed on film or electronically acquired with a Kodak 4000R Image Station (Kodak) equipped with Kodak Imaging Software, version 4.0.
Immunofluorescence. Immunofluorescence analysis of monolayer cells was performed as described (9) . Antibodies used are described in SI Materials and Methods. Nuclei were counterstained with Hoechst 33258. Images were acquired using a Nikon Eclipse TE2000-E with a 60× objective and Metamorph 6.3r7 (Molecular Devices) software.
Coimmunofluorescence microscopy of raft cultures and clinical specimens was performed as described (50) . Nuclei were counterstained with Hoechst 33258. Images were acquired using an Axioplan 2 microscope (Zeiss) with a 63× objective and Axiovision 4.5 (Zeiss) software.
qRT-PCR. Total RNA was extracted using the Total RNA Isolation Mini kit (Agilent). Analysis was performed using a 7300 real-time PCR system (Applied Biosystems) and the QuantiTect SYBR green RT-PCR kit (Qiagen). Primers for KDM6B and KDM6A were purchased from SuperArray. Primers and PCR conditions used for analysis of EZH2 and HOX gene expression (51) are listed in SI Materials and Methods. RNAi. Hkc/HPV16 cells (1.75 × 10 5 ) were seeded onto six-well plates 1 d before transfection with 100 nM KDM6B-specific ON-TARGETplus SMARTpool (L-023013-01; Thermo Scientific Dharmacon) or ON-TARGETplus NonTargeting Pool (D-001810-10; Thermo Scientific Dharmacon) using Lipofectamine 2000 (Invitrogen) . U2OS tet-on and CaSki cells were transfected using FuGene 6 (Roche) with the following shRNA constructs-shKDM6A: TRCN0000107760 (Open Biosystems), shKDM6B: TRCN0000095268 (Open Biosystems), and MISSION Non-Target shRNA control vector (Sigma).
ChIP. ChIP was performed using the EZ ChIP kit (Millipore). Immunoprecipitation of cross-linked chromatin was conducted with antibodies described in SI Materials and Methods. After immunoprecipitation, extracted DNA was amplified by real-time qPCR using oligonucleotide primers described in SI Materials and Methods.
Growth Suppression Experiments. CaSki cells (1 × 10 5 ) were transiently transfected with shcontrol, shKDM6A, or shKDM6B expression vectors. 
